
Chinese non-clinical safety and efficacy evaluation organisation in Huangpu district, Guangzhou, established jointly by the Guangdong-Hong Kong-Macao Greater Bay Area National Nanotechnology Innovation Institute and the National Nano Intelligent Manufacturing Industry Innovation Centre. Describes itself as China's first evaluation body dedicated to nanotechnology medical products, operating to drug GLP, OECD GLP, FDA GLP, Japanese GLP, CNAS, CMA and AAALAC standards. Evaluates non-clinical efficacy and safety of advanced nanomedicine products as well as conventional drugs, medical devices, cosmetics, health foods and foods, and supports clients through clinical trials and marketing applications.
Ver perfil de la empresa
Deja tu valoración